Testing effectiveness (Phase 2)Study completedNCT01445899
What this trial is testing
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
Who this might be right for
Choroidal NeovascularizationDiabetic RetinopathyDiabetic Macular Edema
Quark Pharmaceuticals 258